# Clinic Trial to Evaluate the Safety and Immunogenicity by Different Sequential Schedules of bOPV and IPV

> **NCT03614702** · PHASE3 · COMPLETED · sponsor: **Institute of Medical Biology, Chinese Academy of Medical Sciences** · enrollment: 1200 (actual)

## Conditions studied

- Poliomyelitis

## Interventions

- **BIOLOGICAL:** 1-dose cIPV + 2-doses bOPV (Candy)
- **BIOLOGICAL:** 1-dose sIPV + 2-doses bOPV (Candy)
- **BIOLOGICAL:** 2-doses cIPV + 1-dose bOPV (Candy)
- **BIOLOGICAL:** 2-doses sIPV + 1-dose bOPV (Candy)
- **BIOLOGICAL:** 2-doses cIPV + 1-dose tOPV (Candy)
- **BIOLOGICAL:** 2-doses sIPV + 1-dose tOPV (Candy)
- **BIOLOGICAL:** 1-dose cIPV + 2-doses bOPV (Liquid)
- **BIOLOGICAL:** 1-dose sIPV + 2-doses bOPV (Liquid)
- **BIOLOGICAL:** 2-doses cIPV + 1-dose bOPV (Liquid)
- **BIOLOGICAL:** 2-doses sIPV + 1-dose bOPV (Liquid)
- **BIOLOGICAL:** 2-doses cIPV + 1-dose tOPV (Liquid)
- **BIOLOGICAL:** 2-doses sIPV + 1-dose tOPV (Liquid)

## Key facts

- **NCT ID:** NCT03614702
- **Lead sponsor:** Institute of Medical Biology, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-15
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 1200 (ACTUAL)
- **Last updated:** 2023-10-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03614702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03614702, "Clinic Trial to Evaluate the Safety and Immunogenicity by Different Sequential Schedules of bOPV and IPV". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03614702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*